Clinical Trial Update: Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients

View source ↗

Summary

A completed study evaluates whether Divpenia levels and CD4 counts can predict outcomes in relapsed breast cancer or lung cancer. The update highlights the pote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer

Snippet

Sponsor: Centre Leon Berard | Conditions: Breast Cancer, Lung Cancer | Status: COMPLETED